In the last trading session, 2.84 million shares of the Elanco Animal Health Inc (NYSE:ELAN) were traded, and its beta was 1.41. Most recently the company’s share price was $12.41, and it changed around $0.02 or 0.16% from the last close, which brings the market valuation of the company to $6.13B. ELAN currently trades at a discount to its 52-week high of $18.80, offering almost -51.49% off that amount. The share price’s 52-week low was $8.52, which indicates that the current value has risen by an impressive 31.35% since then. We note from Elanco Animal Health Inc’s average daily trading volume that its 10-day average is 4.35 million shares, with the 3-month average coming to 4.74 million.
Elanco Animal Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.86. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 6 recommended ELAN as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Elanco Animal Health Inc is expected to report earnings per share of 0.12 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elanco Animal Health Inc (NYSE:ELAN) trade information
Instantly ELAN has showed a green trend with a performance of 0.16% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 13.16 on recent trading dayincreased the stock’s daily price by 5.7%. The company’s shares are currently down -16.71% year-to-date, but still down -4.32% over the last five days. On the other hand, Elanco Animal Health Inc (NYSE:ELAN) is -9.61% down in the 30-day period. We can see from the shorts that 11.52 million shares have been sold at a short interest cover period of 2.35 day(s).
The consensus price target as assigned by Wall Street analysts is $27, which translates to bulls needing to increase their stock price by 54.04% from its current value. Analyst projections state that ELAN is forecast to be at a low of $16 and a high of $37.
Elanco Animal Health Inc (ELAN) estimates and forecasts
Elanco Animal Health Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -6.41 percent over the past six months and at a 2.25% annual growth rate that is well below the industry average of 17.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -33.30% in revenue this quarter, and will report an increase of 100.00% in the next quarter. The year-over-year growth rate is expected to be 0.30%, up from the previous year.
Consensus estimates provided by 9 financial analysts predict the company will bring in an average of 1.03B in revenue for the current quarter. 9 analysts expect Elanco Animal Health Inc to make 1.01B in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at -2.20%.
Elanco Animal Health Inc earnings are expected to increase by 3.31% in 2024, but the outlook is positive 10.47% per year for the next five years.
ELAN Dividends
Elanco Animal Health Inc’s next quarterly earnings report is expected to be released in November.
Elanco Animal Health Inc (NYSE:ELAN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.66% of Elanco Animal Health Inc shares, and 99.33% of them are in the hands of institutional investors. The stock currently has a share float of 99.99%. Elanco Animal Health Inc stock is held by 538.0 institutions, with DODGE & COX being the largest institutional investor. By 2024-06-30, it held 16.9471% of the shares, which is about 83.58 million shares worth $1.21 billion.
PRIMECAP MANAGEMENT CO/CA/, with 10.7062% or 52.8 million shares worth $761.94 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
